Last Updated:
Access Report
Name Designation Appointment Date Status
Deeksha Chaudhary

Appointed as Director since December 2025

 Director 16-Dec-2025 Current
Name Designation Appointment Date Status
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Narendra Pratap Kannojia

Appointed as Director since December 2025

 Director 16-Dec-2025 Current

People Timeline

Explore the timeline of key personnel in Pharmavenir Research And Analytic Private Limited's leadership journey.

Contact Details
  • Address Flat 5 Block D Md Tower, Gopanapally, Gachibowli, Serilingampally Telangana, 500046, India
  • Telephone Upgrade
  • Email Upgrade
  • Pin Code 500046
  • Country India
  • Website -
Frequently Asked Questions
How can I contact Pharmavenir Research And Analytic Private Limited?
You can contact Pharmavenir Research And Analytic Private Limited through their registered address at Flat 5 Block D Md Tower, Gopanapally, Gachibowli, Serilingampally Telangana, 500046, India, or via their website if available. Social media links are also provided where applicable.
Who are the current directors of Pharmavenir Research And Analytic Private Limited?
The current directors of Pharmavenir Research And Analytic Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • DEEKSHA CHAUDHARY
  • Narendra Pratap Kannojia
How can I access past director details?
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available